Jump to content

5-MeO-DALT: Difference between revisions

From Wikipedia, the free encyclopedia
Browse history interactively
← Previous editNext edit →
Content deleted Content added
VisualWikitext
No edit summary
update references
Line 31: Line 31:


==Chemistry==
==Chemistry==
The full name of the chemical is ''N''-[[allyl]]-''N''-[2-(5-[[methoxy]]-1H-[[indole|indol]]-3-yl)[[ethyl group|ethyl]]][[propene|prop-2-en-1-]][[amine]]. It is chemically related to the compounds [[5-MeO-DPT]] and [[DALT]].
The full name of the chemical is ''N''-[[allyl]]-''N''-[2-(5-[[methoxy]]-1H-[[indole|indol]]-3-yl)[[ethyl group|ethyl]]][[propene|prop-2-en-1-]][[amine]]. It is related to the compounds [[5-MeO-DPT]] and [[DALT]]. Its metabolism has been described in scientific literature.<ref>{{cite journal | url=http://link.springer.com/article/10.1007%2Fs00216-015-8955-0 | title=Metabolism of the new psychoactive substances N,N-diallyltryptamine (DALT) and 5-methoxy-DALT and their detectability in urine by GC–MS, LC–MS <sup>n</sup> , and LC–HR–MS–MS | author=Julian A. Michely, Andreas G. Helfer, Simon D. Brandt, Markus R. Meyer, Hans H. Maurer | journal=Analytical and Bioanalytical Chemistry | year=2015 | month=August | doi=10.1007/s00216-015-8955-0 | pmid=26297461}}</ref>


==History==
==History==
The first material regarding the synthesis and effects of 5-MeO-DALT was sent from [[Alexander Shulgin]] to a researcher in May 2004, after which it was circulated online. In June 2004 5-MeO-DALT became available from internet [[research chemical]] vendors. In August 2004 the synthesis and effects of 5-MeO-DALT were published by [[Erowid]].<ref name="The Last Interview With Alexander Shulgin">[http://www.viceland.com/int/v17n5/htdocs/the-last-interview-with-alexander-shulgin-423.php?page=5], Morris, H. (11 May 2010). "The Last Interview With Alexander Shulgin". Vice Magazine. Retrieved 2011-02-24.</ref>
The first material regarding the synthesis and effects of 5-MeO-DALT was sent from [[Alexander Shulgin]] to a researcher in May 2004, after which it was circulated online. In June 2004 5-MeO-DALT became available from internet [[research chemical]] vendors. In August 2004 the synthesis and effects of 5-MeO-DALT were published by [[Erowid]].<ref>{{cite web | url=http://www.vice.com/read/the-last-interview-with-alexander-shulgin-423-v17n5 | title=The Last Interview With Alexander Shulgin | publisher=Vice | date=2 May 2010 | accessdate=3 September 2015 | author=Hamilton Morris, Ash Smith}}</ref>


==Dosage==
==Dosage==
Doses ranging from 12–20&nbsp;mg were tested by Alexander Shulgin's research group.<ref name="Alexander Shulgin Speech Germany 2008">[http://www.youtube.com/watch?v=ijXkk4OLDpk]</ref>
Doses ranging from 12–20&nbsp;mg were tested by Alexander Shulgin's research group.<ref>{{cite web | url=https://www.youtube.com/watch?v=ijXkk4OLDpk | title=Sasha Shulgin - 5-MeO-DALT, 2C-B-FLY & 5-EtOs | accessdate=3 September 2015}}</ref>


==Dangers==
==Dangers==
Line 43: Line 43:


==Legal Satus==
==Legal Satus==



===Japan===
===Japan===
5-MeO-DALT became a controlled substance in [[Japan]] from April 2007, by amendment to the [[Pharmaceutical Affairs Law (Japan)|Pharmaceutical Affairs Law]].<ref>{{ cite web | url = http://www.mhlw.go.jp/houdou/2007/08/h0810-3.html | title = 厚生労働省：平成１8年度無承認無許可医薬品等買上調査の結果について | accessdate = 2012-06-26 }} {{ja icon}}</ref>
5-MeO-DALT became a controlled substance in [[Japan]] from April 2007, by amendment to the [[Pharmaceutical Affairs Law (Japan)|Pharmaceutical Affairs Law]].<ref>{{ cite web | url = http://www.mhlw.go.jp/houdou/2007/08/h0810-3.html | title = 厚生労働省：平成１8年度無承認無許可医薬品等買上調査の結果について | language=Japanese | accessdate =24 July 2015 }}</ref>


===United Kingdom===
===United Kingdom===
Line 55: Line 54:


===Sweden===
===Sweden===
[[Riksdag|''Sveriges riksdag'']] added 5-MeO-DALT to schedule I (''"substances, plant materials and fungi which normally do not have medical use"'') as narcotics in Sweden as of May 1, 2012, published by [[Medical Products Agency (Sweden)|''Medical Products Agency'']] in their regulation '''LVFS 2012:6''' listed as '''5-MeO-DALT N-allyl-N-[2-(5-metoxi-1H-indol-3-yl)etyl]-prop-2-en-1-amin'''.<ref>http://www.lakemedelsverket.se/upload/lvfs/LVFS_2012_6.pdf</ref>
[[Riksdag|''Sveriges riksdag'']] added 5-MeO-DALT to schedule I (''"substances, plant materials and fungi which normally do not have medical use"'') as narcotics in Sweden as of May 1, 2012, published by [[Medical Products Agency (Sweden)|''Medical Products Agency'']] in their regulation '''LVFS 2012:6''' listed as '''5-MeO-DALT N-allyl-N-[2-(5-metoxi-1H-indol-3-yl)etyl]-prop-2-en-1-amin'''.<ref>{{cite web | url=https://lakemedelsverket.se/upload/lvfs/LVFS_2012_6.pdf | title=Föreskrifter om ändring i Läkemedelsverkets föreskrifter (LVFS 2011:10) om förteckningar över narkotika | date=20 April 2012 | accessdate=3 September 2015 | language=Swedish | author=Generaldirektör Christina Rångemark Åkerman}}</ref>


===United States===
===United States===
Line 64: Line 63:


====Louisiana====
====Louisiana====
5-MeO-DALT is a Schedule I [[controlled substance]] in the state of [[Louisiana]] making it illegal to buy, sell, or possess in Louisiana. <ref name="Louisiana State Legislature RS 40:963 Schedules of controlled dangerous substances">[http://legis.la.gov/Legis/Law.aspx?d=98877]</ref>
5-MeO-DALT is a Schedule I [[controlled substance]] in the state of [[Louisiana]] making it illegal to buy, sell, or possess in Louisiana.<ref>{{cite web | url=http://legis.la.gov/Legis/Law.aspx?d=98877 | title=Louisiana State Legislature | accessdate=3 September 2015}}</ref>


==Notes==
==Notes==
Line 70: Line 69:


==External links==
==External links==
* [http://www.erowid.org/chemicals/5meo_dalt/5meo_dalt.shtml Erowid 5-MeO-DALT vault]
* [https://www.erowid.org/chemicals/5meo_dalt/5meo_dalt.shtml Erowid 5-MeO-DALT vault]
* [http://www.ukchemicalresearch.org/Thread-5-MeO-DALT 5-MeO-DALT Thread at UKChemicalResearch]
* [https://www.ukchemicalresearch.org/Thread-5-MeO-DALT 5-MeO-DALT Thread at UKChemicalResearch]


{{Entactogens}}
{{Entactogens}}

Revision as of 17:03, 3 September 2015

5-MeO-DALT
Identifiers
  • N-allyl-N-[2-(5-methoxy
    -1H-indol-3-yl)ethyl]
    prop-2-en-1-amine
CAS Number
PubChem CID
ChemSpider
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC17H22N2O
Molar mass270.375 g/mol g·mol−1
3D model (JSmol)
  • C=CCN(CCC1=CNC2=C1C=C(OC)C=C2)CC=C
  • InChI=1S/C17H22N2O/c1-4-9-19(10-5-2)11-8-14-13-18-17-7-6-15(20-3)12-16(14)17/h4-7,12-13,18H,1-2,8-11H2,3H3 checkY
  • Key:HGRHWEAUHXYNNP-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

5-MeO-DALT or N,N-diallyl-5-methoxytryptamine is a psychedelic tryptamine first synthesized by Alexander Shulgin.

Chemistry

The full name of the chemical is N-allyl-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]prop-2-en-1-amine. It is related to the compounds 5-MeO-DPT and DALT. Its metabolism has been described in scientific literature.[1]

History

The first material regarding the synthesis and effects of 5-MeO-DALT was sent from Alexander Shulgin to a researcher in May 2004, after which it was circulated online. In June 2004 5-MeO-DALT became available from internet research chemical vendors. In August 2004 the synthesis and effects of 5-MeO-DALT were published by Erowid.[2]

Dosage

Doses ranging from 12–20 mg were tested by Alexander Shulgin's research group.[3]

Dangers

There are numerous anecdotal reports of users consuming dosages far in excess of those tested by Alexander Shulgin,[citation needed] although there is no published literature on the toxicity of 5-MeO-DALT.

Japan

5-MeO-DALT became a controlled substance in Japan from April 2007, by amendment to the Pharmaceutical Affairs Law.[4]

United Kingdom

5-MeO-DALT became a Class A drug in the UK on January 7th 2015 after an update to the tryptamine blanket ban.

Singapore

5-MeO-DALT is listed in the Fifth Schedule of the Misuse of Drugs Act (MDA) and therefore illegal in Singapore as of May 2015.[5]

Sweden

Sveriges riksdag added 5-MeO-DALT to schedule I ("substances, plant materials and fungi which normally do not have medical use") as narcotics in Sweden as of May 1, 2012, published by Medical Products Agency in their regulation LVFS 2012:6 listed as 5-MeO-DALT N-allyl-N-[2-(5-metoxi-1H-indol-3-yl)etyl]-prop-2-en-1-amin.[6]

United States

5-MeO-DALT is not scheduled at the federal level in the United States,[7] but it is likely that it could be considered an analog of 5-Meo-DiPT or another tryptamine, in which case purchase, sale, or possession could be prosecuted under the Federal Analog Act.

Florida

5-MeO-DALT is a Schedule I controlled substance in the state of Florida making it illegal to buy, sell, or possess in Florida.[8]

Louisiana

5-MeO-DALT is a Schedule I controlled substance in the state of Louisiana making it illegal to buy, sell, or possess in Louisiana.[9]

Notes

  1. ^ Julian A. Michely, Andreas G. Helfer, Simon D. Brandt, Markus R. Meyer, Hans H. Maurer (2015). "Metabolism of the new psychoactive substances N,N-diallyltryptamine (DALT) and 5-methoxy-DALT and their detectability in urine by GC–MS, LC–MS n , and LC–HR–MS–MS". Analytical and Bioanalytical Chemistry. doi:10.1007/s00216-015-8955-0. PMID 26297461. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  2. ^ Hamilton Morris, Ash Smith (2 May 2010). "The Last Interview With Alexander Shulgin". Vice. Retrieved 3 September 2015.
  3. ^ "Sasha Shulgin - 5-MeO-DALT, 2C-B-FLY & 5-EtOs". Retrieved 3 September 2015.
  4. ^ "厚生労働省：平成１8年度無承認無許可医薬品等買上調査の結果について" (in Japanese). Retrieved 24 July 2015.
  5. ^ "CNB NEWS RELEASE". Central Narcotics Bureau (CNB). 30 April 2015. Retrieved 24 July 2015.
  6. ^ Generaldirektör Christina Rångemark Åkerman (20 April 2012). "Föreskrifter om ändring i Läkemedelsverkets föreskrifter (LVFS 2011:10) om förteckningar över narkotika" (PDF) (in Swedish). Retrieved 3 September 2015.
  7. ^ §1308.11 Schedule I.
  8. ^ Florida Statutes - Chapter 893 - DRUG ABUSE PREVENTION AND CONTROL
  9. ^ "Louisiana State Legislature". Retrieved 3 September 2015.
Retrieved from "https://en.wikipedia.org/w/index.php?title=5-MeO-DALT&oldid=679287233"